Search

Your search keyword '"Gotake, Yasuko"' showing total 29 results
Start Over Author "Gotake, Yasuko"
29 results on '"Gotake, Yasuko"'

13. Efficacy of preoperative amino acid supplements on postoperative physical function and complications in open heart surgery patients: A study protocol for a randomized controlled trial

Author

Ogawa, Masato, primary, Yoshida, Naofumi, additional, Satomi-Kobayashi, Seimi, additional, Tsuboi, Yasunori, additional, Komaki, Kodai, additional, Wakida, Kumiko, additional, Gotake, Yasuko, additional, Inoue, Takeshi, additional, Tanaka, Hiroshi, additional, Yamashita, Tomoya, additional, Sakai, Yoshitada, additional, Izawa, Kazuhiro P., additional, Takahashi, Michiko, additional, Ogawa, Wataru, additional, and Hirata, Ken-ichi, additional

Published
2019
Full Text
View/download PDF

16. Type II Endoleak After Endovascular Aortic Aneurysm Repair Using the Endurant Stent Graft System for Abdominal Aortic Aneurysm with Occluded Inferior Mesenteric Artery

Author

Gentsu, Tomoyuki, primary, Okada, Takuya, additional, Yamaguchi, Masato, additional, Horinouchi, Hiroki, additional, Katayama, Naoto, additional, Ueshima, Eisuke, additional, Koide, Yutaka, additional, Sofue, Keitaro, additional, Gotake, Yasuko, additional, Nomura, Yoshikatsu, additional, Tanaka, Hiroshi, additional, Okita, Yutaka, additional, Sugimoto, Koji, additional, and Murakami, Takamichi, additional

Published
2018
Full Text
View/download PDF

17. The fate of the downstream aorta after open aortic repair for acute DeBakey type I aortic dissection: total arch replacement with elephant trunk technique versus non-total arch replacement†

Author

Ikeno, Yuki, primary, Yokawa, Koki, additional, Koda, Yojiro, additional, Gotake, Yasuko, additional, Henmi, Soichiro, additional, Nakai, Hidekazu, additional, Yamanaka, Katsuhiro, additional, Inoue, Takeshi, additional, Tanaka, Hiroshi, additional, and Okita, Yutaka, additional

Published
2018
Full Text
View/download PDF

24. The fate of the downstream aorta after open aortic repair for acute DeBakey type I aortic dissection: total arch replacement with elephant trunk technique versus non-total arch replacement.

Author

Ikeno, Yuki, Yokawa, Koki, Koda, Yojiro, Gotake, Yasuko, Henmi, Soichiro, Nakai, Hidekazu, Yamanaka, Katsuhiro, Inoue, Takeshi, Tanaka, Hiroshi, and Okita, Yutaka

Subjects
AORTIC dissection, THORACIC aorta, BLOOD vessel prosthesis, AORTA, HOSPITAL mortality, ELEPHANTS
Abstract

View large Download slide View large Download slide OBJECTIVES The aim of this study was to evaluate the fate of the downstream aorta following open aortic repair for acute DeBakey type I aortic dissection comparing total arch replacement (TAR) with the elephant trunk (ET) technique versus non-total arch replacement (non-TAR). METHODS From October 1999 to December 2016, 267 patients underwent open repair for acute DeBakey type I aortic dissection. A tear-oriented strategy was mainly used to determine the extent of graft replacement. Hospital mortality was 10.0% (12/120 patients) in the TAR group and 17.0% (25/147 patients) in the non-TAR group (P  = 0.070). Late outcomes were compared in 230 hospital survivors (TAR: n  = 108 and non-TAR: n  = 122). Mean follow-up was 6.5 ± 4.6 years. The aortic diameters were measured at 4 levels, across 6 time points using computed tomography. RESULTS Freedom from additional aortic surgery for distal dilation was significantly better in the TAR group than the non-TAR group (TAR: 97.5 ± 1.8% at 5 years and non-TAR: 88.2 ± 3.4% at 5 years, P  = 0.045). Freedom from a distal aortic event was also significantly better in the TAR group compared with the non-TAR group (TAR: 97.2 ± 1.6% at 5 years and non-TAR: 80.7 ± 4.2% at 5 years, P  = 0.013). In the non-TAR group, the aortic arch diameter significantly increased (P  < 0.001). Significant aortic remodelling occurred at the proximal descending aorta in the TAR with ET group (P  < 0.001). CONCLUSIONS The TAR with ET reduced the need for additional distal aortic repair compared to non-TAR. TAR with ET prevented unfavourable aortic growth in both the aortic arch and the proximal descending aorta. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

26. Strategies for the treatment of aorto-oesophageal fistula†

Author

Okita, Yutaka, primary, Yamanaka, Katsuhiro, additional, Okada, Kenji, additional, Matsumori, Masamichi, additional, Inoue, Takeshi, additional, Fukase, Keigo, additional, Sakamoto, Toshihito, additional, Miyahara, Shunsuke, additional, Shirasaka, Tomonori, additional, Izawa, Naoto, additional, Ohara, Taimi, additional, Nomura, Yoshikatsu, additional, Nakai, Hidekazu, additional, Gotake, Yasuko, additional, and Kano, Hiroya, additional

Published
2014
Full Text
View/download PDF

29. Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke.

Author

Sakamoto T, Kano H, Miyahara S, Inoue T, Izawa N, Gotake Y, Matsumori M, Okada K, and Okita Y

Subjects
Adult, Aged, Anticoagulants administration & dosage, Anticoagulants adverse effects, Benzamidines, Blood Coagulation Tests, Drug Monitoring methods, Female, Humans, Japan epidemiology, Male, Middle Aged, Perioperative Care methods, Radiography, Retrospective Studies, Risk Adjustment, Time-to-Treatment, Treatment Outcome, Cardiac Surgical Procedures adverse effects, Cardiac Surgical Procedures methods, Cardiopulmonary Bypass methods, Endocarditis complications, Endocarditis diagnosis, Endocarditis mortality, Endocarditis surgery, Guanidines administration & dosage, Guanidines adverse effects, Intracranial Hemorrhages diagnostic imaging, Intracranial Hemorrhages etiology, Intracranial Hemorrhages mortality, Intraoperative Complications prevention & control
Abstract

Background and Aim of the Study: Recent brain complications (e.g., bleeding or infarction) in patients with active infective endocarditis (AIE) are recognized as a contraindication for early surgery. Nafamostat mesilate (NM) is a synthetic protease-inhibiting agent that has not only potent inhibitory activity against coagulation factors (Xlla, Xa) but also an anti-inflammatory action. Herein is reported the authors' successful surgical experience using NM with low-dose heparinization in patients with AIE complicated by recent cerebral complications., Methods: Twenty-eight patients (mean age 54.9 +/- 18.7 years) who had undergone surgery for AIE of the native valve (n = 21) or prosthetic valve (n = 7) were reviewed retrospectively. AIE was present in the aortic (n = 8), mitral (n = 16), aortic/mitral (n = 4) and tricuspid (n = 1) valves. Twenty-two of 28 patients had preoperative stroke, and six had active brain bleeding. Surgery was performed at a mean of 2.4 +/- 2.1 days after the onset of stroke. NM (209 +/- 152 mg) with low-dose heparin (3796 +/- 1218 IU; 67.4 +/- 20.3 IU/kg) was used for anticoagulation during cardiopulmonary bypass (CPB). The activated clotting time (ACT) was maintained at 350-450 s by the precise administration of NM into a cardiotomy reservoir (0.5 mg/kg/h) and a venous reservoir (sliding controlled dose at 1.5 mg/kg/h)., Results: The CPB time was 181.3 +/- 92.6 min. Five patients (17.8%) died during hospitalization due to persistent sepsis (n = 3), brain death caused by massive brain embolism before CPB establishment (n = 1), and pneumonia (n = 1). There was no further aggravation of intracranial bleeding, and no new hemorrhagic stroke., Conclusion: Nafamostat mesilate, administered in conjunction with low-dose heparinization, served as an effective anticoagulant for early surgery in patients with AIE complicated by stroke, and caused no further deterioration of the cerebral lesions.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results